These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 7583441)
1. The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection. Iacobelli S; Ullrich A; Tinari N; Ortona L; Tamburrini E; D'Egidio M; Ghinelli F; Sighinolfi L; Piazza M; Chirianni A J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):450-6. PubMed ID: 7583441 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191 [TBL] [Abstract][Full Text] [Related]
3. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV-infected injection drug users. Zabay JM; Sempere JM; Benito JM; Gonzalez B; Obregón E; Díez J; Fernández-Cruz E J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar; 8(3):266-72. PubMed ID: 7859138 [TBL] [Abstract][Full Text] [Related]
4. A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men. Briggs NC; Natoli C; Tinari N; D'Egidio M; Goedert JJ; Iacobelli S AIDS Res Hum Retroviruses; 1993 Sep; 9(9):811-6. PubMed ID: 7504933 [TBL] [Abstract][Full Text] [Related]
5. Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection. Lifson AR; Hessol NA; Buchbinder SP; O'Malley PM; Barnhart L; Segal M; Katz MH; Holmberg SD Lancet; 1992 Jun; 339(8807):1436-40. PubMed ID: 1351128 [TBL] [Abstract][Full Text] [Related]
6. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Mellors JW; Kingsley LA; Rinaldo CR; Todd JA; Hoo BS; Kokka RP; Gupta P Ann Intern Med; 1995 Apr; 122(8):573-9. PubMed ID: 7887550 [TBL] [Abstract][Full Text] [Related]
7. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific. Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311 [TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection. Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448 [TBL] [Abstract][Full Text] [Related]
9. Serum beta 2-microglobulin in intravenous drug users and its correlation with human immunodeficiency virus infection. Chironna M; Fanelli M; Potenza D; Serio G; Quarto M Int J Clin Lab Res; 1994; 24(2):90-3. PubMed ID: 7919434 [TBL] [Abstract][Full Text] [Related]
10. Immune activation markers and AIDS prognosis. Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808 [TBL] [Abstract][Full Text] [Related]
11. The predictive value of several markers in the progression to acquired immunodeficiency syndrome. Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805 [TBL] [Abstract][Full Text] [Related]
12. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection]. Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488 [TBL] [Abstract][Full Text] [Related]
13. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS. Krown SE; Niedzwiecki D; Bhalla RB; Flomenberg N; Bundow D; Chapman D J Acquir Immune Defic Syndr (1988); 1991; 4(9):871-80. PubMed ID: 1895208 [TBL] [Abstract][Full Text] [Related]
14. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion. Farzadegan H; Henrard DR; Kleeberger CA; Schrager L; Kirby AJ; Saah AJ; Rinaldo CR; O'Gorman M; Detels R; Taylor E; Phair JP; Margolick JB J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):448-55. PubMed ID: 8970472 [TBL] [Abstract][Full Text] [Related]
15. Close relationships between neopterin and beta-2-microglobulin levels in intravenous drug abusers. Lin RY; Nygren E; Valinsky J; Lorenzana FG; Ralph H Int Arch Allergy Appl Immunol; 1990; 91(4):389-93. PubMed ID: 1976599 [TBL] [Abstract][Full Text] [Related]
16. Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. Multicenter AIDS Cohort Study. Shi M; Taylor JM; Currier RJ; Tang H; Hoover DR; Chmiel JS; Bryant JL J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):309-16. PubMed ID: 8673537 [TBL] [Abstract][Full Text] [Related]
17. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy. Siller L; Martin NL; Kostuchenko P; Beckett L; Rautonen J; Cheng SC; Wara DW AIDS; 1993 Mar; 7(3):369-73. PubMed ID: 8097095 [TBL] [Abstract][Full Text] [Related]
18. Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus. Senaldi G; Peakman M; Natoli C; Hussain MJ; Gallati H; McManus T; Vergani D; Iacobelli S J Infect; 1994 Jan; 28(1):31-9. PubMed ID: 8163831 [TBL] [Abstract][Full Text] [Related]
19. Relationship of circulating CD4+ T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV-infected subjects with oral hairy leukoplakia. Ravina A; Ficarra G; Chiodo M; Mazzetti M; Romagnani S J Oral Pathol Med; 1996 Mar; 25(3):108-11. PubMed ID: 9148036 [TBL] [Abstract][Full Text] [Related]
20. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]